Harbour Investments’s Cellectis CLLS Stock Holding History

Harbour Investments’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5K	Hold	4,500	–	–	﹤0.01%	3177
2026 Q1	$14.3K	Hold	4,500	–	–	﹤0.01%	3081
2025 Q4	$21.8K	Hold	4,500	–	–	﹤0.01%	2383
2025 Q3	$12.8K	Hold	4,500	–	–	﹤0.01%	2564
2025 Q2	$6.86K	Hold	4,500	–	–	﹤0.01%	2736
2025 Q1	$5.58K	Hold	4,500	–	–	﹤0.01%	2781
2024 Q4	$8.1K	Sell	4,500 -1,600	-26%	-$2.98K	﹤0.01%	2541
2024 Q3	$12.9K	Hold	6,100	–	–	﹤0.01%	2245
2024 Q2	$11.4K	Hold	6,100	–	–	﹤0.01%	2196
2024 Q1	$16.2K	Buy	+6,100	New	+$16.9K	﹤0.01%	2047
2021 Q4	–	Sell	-1,646	Closed	-$21K	–	2801
2021 Q3	$21K	Buy	1,646 +379	+30%	+$5.25K	﹤0.01%	2262
2021 Q2	$20K	Sell	1,267 -781	-38%	-$13.1K	﹤0.01%	2337
2021 Q1	$41K	Buy	+2,048	New	+$50.6K	﹤0.01%	1799

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments's CLLS Position: Q2 2026 in Review

Harbour Investments held its Cellectis (CLLS) position steady in Q2 2026 at 4,500 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Harbour Investments first reported a position in CLLS in Q1 2021 and has held it in 13 quarters since. The position peaked at $41K in Q1 2021. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

Harbour Investments held 4,500 shares of Cellectis worth $13.5K as of Q2 2026.
Harbour Investments left its Cellectis share count unchanged in Q2 2026.
Cellectis made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3177 holding.
Harbour Investments first reported a position in Cellectis in Q1 2021 and has held it in 13 quarters since.
Harbour Investments's Cellectis position peaked at $41K in Q1 2021.
27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.